FTC sues main pharmacy reward professionals above insulin rates The agency introduced action versus Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist price of lifestyle-preserving insulin prescription drugs. The deal needs to be concluded by Sept. 30 or buyers can terminate https://busch-light-peach-nutriti42840.jts-blog.com/29913174/the-smart-trick-of-healthcare-news-that-nobody-is-discussing